Market Value188,660,000
Total Holdings62
File Date2021-02-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AXSM / Axsome Therapeutics, Inc.
STRO / Sutro Biopharma, Inc.
SIOX / Sio Gene Therapies Inc.
ATNX / Athenex Inc
US761299AB20 / Retrophin Inc Bond
SLDB / Solid Biosciences Inc. Call
US92538T1043 / VESPER HEALTHCARE ACQUISITION CORP A
OM / Outset Medical, Inc.
LUNG / Pulmonx Corporation
BBIO / BridgeBio Pharma, Inc.
CHAQ / Chardan Healthcare Acquisition 2 Corp
OCUL / Ocular Therapeutix, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
VXRT / Vaxart, Inc. Put
US92731L1145 / Vincerx Pharma, Inc.
US92538T1126 / Vesper Healthcare Acquisition Corp - Warrants
BYSI / BeyondSpring Inc.
DRNA / Dicerna Pharmaceuticals Inc
LYRA / Lyra Therapeutics, Inc.
US5431951012 / Longview Acquisition Corp.
CCCC / C4 Therapeutics, Inc.
ZYME / Zymeworks Inc.
/ Cerevel Therapeutics Holdings, Inc. Warrant
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
LSAQ / LifeSci Acquisition II Corp
NAUT / Nautilus Biotechnology, Inc.
/ Pandion Therapeutics Inc
TNGX / Tango Therapeutics, Inc.
KDNY / Chinook Therapeutics Inc
LPTX / Leap Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
CYCC / Cyclacel Pharmaceuticals, Inc.
MRTX / Mirati Therapeutics, Inc.
XLRN / Acceleron Pharma Inc
HSAQ / Health Sciences Acquisitions Corp 2
RCKT / Rocket Pharmaceuticals, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
CRIS / Curis, Inc.
SNDX / Syndax Pharmaceuticals, Inc. Call
HZNP / Horizon Therapeutics Plc
CRSP / CRISPR Therapeutics AG
ZYNE / Zynerba Pharmaceuticals Inc
CERE / Cerevel Therapeutics Holdings, Inc.
ARKG / ARK ETF Trust - ARK Genomic Revolution ETF Put
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
KURA / Kura Oncology, Inc.
IMTXW / Immatics N.V. - Equity Warrant
MGTX / MeiraGTx Holdings plc
GBT / Global Blood Therapeutics Inc.
VINC / Vincerx Pharma, Inc.
AXSM / Axsome Therapeutics, Inc. Call
PCVX / Vaxcyte, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
SPY / SPDR S&P 500 ETF Put
MRSN / Mersana Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
CYTK / Cytokinetics, Incorporated
ALDX / Aldeyra Therapeutics, Inc.
MORF / Morphic Holding, Inc.
NARI / Inari Medical, Inc.